Emerging trends and promises of nanoemulsions in therapeutics of infectious diseases

Nanomedicine (Lond). 2022 May;17(11):793-812. doi: 10.2217/nnm-2022-0006. Epub 2022 May 19.

Abstract

Infectious diseases are prevalent and have contributed to high morbidity rates by creating havoc like the COVID-19, 1918 influenza and Black Death (the plague) pandemics. Antimicrobial resistance, adverse effects, the emergence of co-infections and the high cost of antimicrobial therapies are major threats to the health of people worldwide while impacting overall healthcare and socioeconomic development. One of the most common ways to address this issue lies in improving existing antimicrobial drug-delivery systems. Nanoemulsions and their modified forms have been successfully employed for the delivery of antimicrobials to treat infectious diseases. In this article, the authors comprehensively reviewed how nanoemulsion-based formulation systems are shifting the paradigm for therapeutics and diagnosis of infectious diseases.

Keywords: antimicrobials; immunization; infectious diseases; modified nanoemulsions; nanoemulsions; nanotechnology.

Publication types

  • Review

MeSH terms

  • Anti-Bacterial Agents
  • Anti-Infective Agents*
  • COVID-19 Drug Treatment*
  • Communicable Diseases* / drug therapy
  • Emulsions
  • Humans

Substances

  • Anti-Bacterial Agents
  • Anti-Infective Agents
  • Emulsions